A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
Clinical trial NCT04761627 · COMPLETED
Trial details
- NCT number
- NCT04761627
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-24
- Primary completion
- 2023-02-28
- Enrollment
- 494
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.